Working... Menu

Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02069899
Recruitment Status : Recruiting
First Posted : February 24, 2014
Last Update Posted : May 10, 2019
Supported by a grant of the 7th framework programme "FP7" from the European Committee
Information provided by (Responsible Party):
NovImmune SA

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2020
  Study Completion Date : No date given